Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral furosemide for postpartum hypertension in women with preeclampsia
IRCT20230722058884N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of furosemide in preeclampsia (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Prevalence of persistent hypertension on postpartum day 5. Started Sep 2023; status: completed.
02
Drugs
furosemide
03
Conditions
preeclampsia
Beyond the preview
Go deeper on IRCT20230722058884N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230722058884N1.